General Biologicals Corporation (TPEX:4117)
Taiwan · Delayed Price · Currency is TWD 11.40
-0.05 (-0.44%)
Mar 6, 2026, 10:57 AM CST
General Biologicals Market Cap
General Biologicals has a market cap or net worth of 696.45 million as of March 5, 2026. Its market cap has decreased by -39.74% in one year.
Market Cap
696.45M
Enterprise Value
3.02B
Revenue
251.38M
Ranking
n/a
PE Ratio
n/a
Stock Price
11.40
Market Cap Chart
Since February 21, 2005, General Biologicals's market cap has increased from 326.98M to 696.45M, an increase of 113.00%. That is a compound annual growth rate of 3.66%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 5, 2026 | 696.45M | -10.89% |
| Dec 31, 2025 | 781.60M | -38.66% |
| Dec 31, 2024 | 1.27B | -21.11% |
| Dec 29, 2023 | 1.62B | 0.37% |
| Dec 30, 2022 | 1.61B | -22.70% |
| Dec 30, 2021 | 2.08B | -35.56% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Tien Liang BioTech | 1.66B |
| InnoPharmax | 1.64B |
| Winston Medical Supply | 1.49B |
| DV Biomed | 1.36B |
| Excelsior Biopharma | 1.24B |
| Anxo Pharmaceutical | 1.14B |
| Original BioMedicals | 1.12B |
| Mediera | 1.09B |